Stem Cells Market Is Projected To Witness Growth Based On Increasing Increasing R&D To Develop Therapeutic Solution For Chronic Diseases Till 2020:Grand View Research,inc.

The global stem cells market size is expected to reach USD 170.15 billion by 2020, according to a new report by Grand View Research, Inc. The market is expected to grow because of increasing research and development to develop therapeutic solution for chronic diseases and the huge funding by the government for drug discovery and development to serve the large unmet medical needs.

The WHO statistics on Cancer (2012) concluded that it is the leading cause for global mortality and morbidity, with around 14 million new cancer cases and 8.2 million cancer related deaths which is estimated to reach 22 million in next two decades. Stem cells in combination with gene therapy along with DNA repair is anticipated to be used to treat many intractable diseases and is classified under orphan drugs.

The California’s Stem Cell Agency has spent around USD 1.4 billion for stem cell research and still has USD 872 million to provide for the same. In addition to this, in 2013 the National Institute of Health has funded around USD1.3 million stem cell researches.

Browse full research report on Stem Cells Market: http://www.grandviewresearch.com/industry-analysis/stem-cells-market

Adult stem cell leads the market due to low contamination during sub-culture and expansion, relatively low labor production and compatibility with the human body. Induced pluripotent stem cells are expected to report revenue of over USD 4.5 billion by 2020, on account of analogous nature of its origin.

Different types of technologies include cell acquisition, cryopreservation, cell production, expansion and sub-culture. For any technique in stem cell production, stem cell acquisition is the basic step; hence, this segment is likely to dominate the market with revenues estimated at USD 10.9 billion by 2020.

Application of stem cell in regenerative medicines is exponentially increasing and hence dominates the market as compared to its application in drug discovery and medicine. Geographical presence of stem cell market is in North America, Asia Pacific, Europe and rest of the world. North America held the largest industry share due to huge government funding and initiative for stem cell research and rise in the acceptance of stem cell therapies.

However, Asia-Pacific is expected to be the fastest growing segment with a CAGR of over 25.0% due to rising contract research outsourcing and medical tourism. Key industry contributors include Advanced Cell Technology Inc., CellartisAB, Cellular Engineering Technologies Inc., BioTime Inc. and International Stem Cell Corporation.

In March 2015, International Stem Cell Corporation received patent from Japan for it human cell bank production from pathogenically activated eggs. This is in alignment with the companies’ strategy to make its intellectual property position strong and also develop relationship with Japan. Moreover, in June 2015, Cellaris AB launched a new xeno free culture called Cellartis EF-CS.
Factors such as government funding, key player engagement to update the techniques, collaboration with domestic players for country specific market entry are expected to boom the stem cell market.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology    
   
Grand View Research has segmented the global stem cells market on the basis of product, 
application, technology and region: 

Stem Cells Product Outlook
  • Stem Cells Platforms
    • Sequence Analysis Platforms
  • Adult Stem Cells
    • Hematopoietic Stem Cells
    • Mesenchymal Stem Cells
    • Neuronal Stem Cells
    • Dental Stem Cells
    • Umbilical Cord Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells
  • Natural Rosette Cells
  • Very Small Embryonic Like Stem Cells
Stem Cells Application Outlook
  • Regenerative Medicine
    • Neurology
    • Orthopedics
    • Oncology
    • Hematology
    • Cardiovascular and Myocardial Infraction
    • Injuries
    • Diabetes
    • Liver Disorder
    • Incontinence
    • Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
  • Drug Discovery and Development
Stem Cells Technology Outlook
  • Cell Acquisition
    • Bone Marrow Harvest
    • Apheresis
    • Umbilical Blood Cord
  • Cell Production
    • Therapeutic Cloning
    • In Vitro Fertilization
    • Isolation
    • Cell Culture
  • Cryopreservation
  • Expansion and Sub-Culture
Stem Cells Regional Outlook
    • North America
    • Europe
    • Asia Pacific
    • RoW
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

The global  vein illuminator market  is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, a...
Read more

Surgical Drainage Devices Market Is Anticipated To Reach $2.3 Billion By 2025: Grand View Research, Inc.

Image
The global  surgical drainage devices market  is anticipated to reach USD 2.3 billion by 2025, according to a new report by Grand View Research, Inc. The growth of this market is catapulted by increasing incidence of chronic diseases, the need to curb healthcare expenditure, and additional benefits associated with surgical drain devices. Majority of the times, these devices are used for prevention of fluid accumulation and in postsurgical treatment & care.  With the escalating number of diseases that require surgical intervention, these devices are now being used in hospitals, clinics, and ambulatory surgical centers. Active surgical drain devices make use of negative pressure or vacuum to remove fluid buildup, and are preferred over conventional passive drain devices as they help in healing the wound quickly. Drainage devices are used in cardiothoracic surgeries, neurosurgical procedures, orthopedic surgeries, and abdominal surgeries among others. Global r...
Read more

Small Animal Imaging Market To Be Driven By Increasing The Number Of Pharmaceutical & Research Organizations Till 2022:Grand View Research,inc.

Global  Small Animal Imaging (In-Vivo) market   is expected to reach USD 2.7 billion by 2022, according to a new study by Grand View Research, Inc. Growing number of medical conditions requiring accurate research for development of treatment options is expected to enhance demand for small animal imaging (in-Vivo) over the forecast period. Importance of these devices in applications such as epigenetic research studies, drug receptor targeting, and defining mechanism of action is estimated to provide potential growth platform for this industry.  The major factors driving the growth of small animal imaging (in-vivo) market are growing usage of multi-functional pre-clinical imaging, rising investments of CROs in pre-clinical studies, increasing number of pharmaceutical and research organizations and technical innovations such as high-resolution MRI with other modalities. Browse full research report on Small Animal Imaging Market: http://www.grandviewresearch.c...
Read more